IMMUNEWALK THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 11 Sept 2026)
What this means for you
Not registered yet, but its 02 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98252420
- Mark type
- Stylized text
- Filed
- 02 Nov 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, Inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for regulating immune response; Nutritional and dietary supplements for immune system support
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical, biopharmaceutical, and biotechnology fields; research and development of pharmaceutical preparations and medicines; medical and scientific research services; pharmaceutical and biopharmaceutical product evaluation; consulting in the field of pharmaceutical, biopharmaceutical, and biotechnology research; testing of pharmaceuticals; scientific laboratory services and medical research laboratory services.
Owner
- ImmuneWalk Therapeutics Inc., Pearl River, NY, US
- ImmuneWalk Therapeutics Inc., Pearl River, NY, US
Prosecution history
- 11 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2026 — SOU EXTENSION 4 GRANTED
- 11 Sept 2026 — SOU EXTENSION 4 FILED
- 11 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 27 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 May 2026 — SOU EXTENSION 3 GRANTED
- 26 May 2026 — SOU EXTENSION 3 FILED
- 26 May 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Nov 2025 — SOU EXTENSION 2 GRANTED
- 26 Nov 2025 — SOU EXTENSION 2 FILED
- 26 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2025 — ASSIGNED TO EXAMINER
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2025 — SOU EXTENSION 1 GRANTED